Immunotherapy Cancer Types
Immunotherapy is a form of cancer treatment that uses the power of the body’s immune system to prevent, control, and eliminate cancer.
From the preventive vaccine for cervical and liver cancer to the first therapy ever proven to extend the lives of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a number of cancers. However, every cancer type is unique, and immunology and immunotherapy are impacting each cancer in different ways.
Explore immunotherapies by cancer type and explore different kinds of treatment, why immunotherapy matters, and how to support cancer immunotherapy research.
Bladder Cancer
The first FDA-approved immunotherapy treatment—Bacillus Calmette-Guérin cancer vaccine—was for bladder cancer in 1990.
Brain Cancer
Cancers of the brain and nervous system are
relatively rare but very serious. Immunotherapy is showing significant promise.
Breast Cancer
New breast cancer immunotherapy treatments have shown great promise, with the potential for long-term success.
Cervical Cancer
Three preventive cancer vaccines are already
helping to stop cervical cancer, with new clinical
trials now available to patients.
Childhood Cancer
Immunotherapy offers a potential way to treat
childhood (pediatric) cancer without the damaging, long-term side effects of conventional treatments.
Colorectal Cancer
There are several FDA-approved immunotherapies for colorectal cancer, for which patients are in urgent need of new treatment options.
Esophageal Cancer
Immunotherapy for esophageal cancer is being
explored to reduce recurrence as a first-line
treatment option.
Head and Neck Cancer
Immunotherapy offers treatment options for
patients with cancers of the mouth, throat, voice
box, sinuses, nose, and salivary glands.
Kidney Cancer
Immunotherapy for kidney cancer—also called renal cell cancer—has tremendously changed the overall survival of patients.
Leukemia
There are several FDA-approved immunotherapies for leukemia (leukaemia) and ongoing research demonstrates even greater potential for new treatments.
Liver Cancer
In addition to the first FDA-approved hepatitis B
cancer vaccine, immunotherapy increases the
immune response to liver cancer.
Lung Cancer
Immunotherapy is a promising option for advanced lung cancer, alone or in combination with treatments like chemotherapy or surgery.
Lymphoma
Several FDA-approved immunotherapies offer
treatment options to children and adults with
Hodgkin and non-Hodgkin lymphoma.
Melanoma
Immunotherapy has changed the way melanoma is treated. In particular, checkpoint inhibitors are
responsible for the increasing survival rate…
Multiple Myeloma
Immunotherapy for multiple myeloma is a promising new treatment option, with the potential to result in long-term cancer remission…
Ovarian Cancer
Research into immunotherapy for ovarian cancer is promising, especially since more treatment options for patients and oncologists are urgently…
Pancreatic Cancer
Pancreatic cancer has few treatment options, so
pancreatic cancer immunotherapy research is vital to providing patients with new hope.
Prostate Cancer
With a cancer vaccine and checkpoint inhibitor
already approved, immunotherapy research offers new hope to patients with advanced prostate…
Sarcoma
Immunotherapy for sarcoma has some success
cases, including the earliest known instances of
spontaneous regression, although sarcoma cancer immunology…
Skin Cancer
Skin cancers are common, often diagnosed at an
early stage, and among the first cancers to respond to immunotherapy.
Stomach Cancer
Immunotherapies, including checkpoint inhibitors and targeted antibodies, offer promising new treatment options for stomach (gastric) cancer patients.
Uterine (Endometrial) Cancer
Immunotherapy for uterine (endometrial) cancer is an emerging area of research and treatment,
especially for patients with advanced cases….